In agreement with the HCC cell data, there was an increase in the mRNA levels and protein expression levels of PFN1 in the lung tumor nodules from GUTK-treated mice in a dose-dependent manner (Figure 5B and 5C). The gene discussed is PFN1; the disease is neoplasm.